Rhenman & Partners Asset Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.61M | Buy |
|
|||||
|
2025
Q1 | $618K | Sell |
|
|||||
|
2024
Q4 | $6.24M | Sell |
|
|||||
|
2024
Q3 | $10.6M | Buy |
|
|||||
|
2024
Q2 | $2.12M | Sell |
|
|||||
|
2024
Q1 | $10.5M | Buy |
|
|||||
|
2023
Q4 | $6.01M | Sell |
|
|||||
|
2023
Q3 | $8.18M | Buy |
|
|||||
|
2023
Q2 | $17.3M | Buy |
|
|||||
|
2023
Q1 | $12.2M | Sell |
|
|||||
|
2022
Q4 | $10.3M | Sell |
|
|||||
|
2022
Q3 | $13.3M | Buy |
|
|||||
|
2022
Q2 | $9.5M | Sell |
|
|||||
|
2022
Q1 | $19.2M | Sell |
|
|||||
|
2021
Q4 | $20.6M | Sell |
|
|||||
|
2021
Q3 | $18.5M | Buy |
|
|||||
|
2021
Q2 | $19.3M | Buy |
|
|||||
|
2021
Q1 | $11.6M | Hold |
|
|||||
|
2020
Q4 | $15.4M | Buy |
|
|||||
|
2020
Q3 | $6.79M | Buy |
|
|||||
|
2020
Q2 | $5.39M | Buy |
|
|||||
|
2020
Q1 | $2.68M | Buy |
|
|||||
|
2019
Q4 | $2.45M | Buy |
|